TY - JOUR
T1 - French consensus on management of head and neck cancer surgery during COVID-19 pandemic
AU - French Society of Otorhinolaryngology, Head and Neck Surgery (SFORL)
AU - French Society of Head and Neck Carcinology (SFCCF)
AU - Fakhry, N.
AU - Schultz, P.
AU - Morinière, S.
AU - Breuskin, I.
AU - Bozec, A.
AU - Vergez, S.
AU - de Garbory, L.
AU - Hartl, D.
AU - Temam, S.
AU - Lescanne, E.
AU - Couloigner, V.
AU - Barry, B.
N1 - Publisher Copyright:
© 2020 Elsevier Masson SAS
PY - 2020/5/1
Y1 - 2020/5/1
N2 - In the context of the current pandemic, there is a need for specific advice concerning treatment of patients with Head and Neck cancers. The rule is to limit as much as possible the number of patients in order to reduce the risks of contamination by the SARS-Cov-2 virus for both patients and the caregivers, who are particularly exposed in ENT. The aim is to minimize the risk of loss of opportunity for patients and to anticipate the increased number of cancer patients to be treated at the end of the pandemic, taking into account the degree of urgency, the difficulty of the surgery, the risk of contaminating the caregivers (tracheotomy) and the local situation (whether or not the hospital and intensive care departments are overstretched).
AB - In the context of the current pandemic, there is a need for specific advice concerning treatment of patients with Head and Neck cancers. The rule is to limit as much as possible the number of patients in order to reduce the risks of contamination by the SARS-Cov-2 virus for both patients and the caregivers, who are particularly exposed in ENT. The aim is to minimize the risk of loss of opportunity for patients and to anticipate the increased number of cancer patients to be treated at the end of the pandemic, taking into account the degree of urgency, the difficulty of the surgery, the risk of contaminating the caregivers (tracheotomy) and the local situation (whether or not the hospital and intensive care departments are overstretched).
KW - COVID
KW - COVID-19
KW - ENT
KW - Head and neck cancer
KW - SARS-Cov-2
UR - http://www.scopus.com/inward/record.url?scp=85083091753&partnerID=8YFLogxK
U2 - 10.1016/j.anorl.2020.04.008
DO - 10.1016/j.anorl.2020.04.008
M3 - Article
C2 - 32303485
AN - SCOPUS:85083091753
SN - 1879-7296
VL - 137
SP - 159
EP - 160
JO - European Annals of Otorhinolaryngology, Head and Neck Diseases
JF - European Annals of Otorhinolaryngology, Head and Neck Diseases
IS - 3
ER -